Cargando…

Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells

Hepatocellular carcinoma (HCC) is a complex process that plays an important role in its progression. Abnormal glucose metabolism in HCC cells can meet the nutrients required for the occurrence and development of liver cancer, better adapt to changes in the surrounding microenvironment, and escape th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qiuyue, Liu, Jinchen, Lin, Haifeng, Lin, Bo, Zhu, Mingyue, Li, Mengsen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Open Exploration Publishing 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344893/ https://www.ncbi.nlm.nih.gov/pubmed/37455832 http://dx.doi.org/10.37349/etat.2023.00149

Ejemplares similares

Alpha fetoprotein promotes polarization of macrophages towards M2-like phenotype and inhibits macrophages to phagocytize hepatoma cells
por: Zhang, Minni, et al.
Publicado: (2023)

IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma
por: Xu, Junnv, et al.
Publicado: (2021)

GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes
por: Feng, Haipeng, et al.
Publicado: (2019)

Ropivacaine promotes apoptosis of hepatocellular carcinoma cells through damaging mitochondria and activating caspase-3 activity
por: Wang, Wenting, et al.
Publicado: (2019)

Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells
por: Lu, Yan, et al.
Publicado: (2016)

Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects
por: Shang, Run-Ze, et al.
Publicado: (2016)

Overexpression of GATA5 Stimulates Paclitaxel to Inhibit Malignant Behaviors of Hepatocellular Carcinoma Cells
por: Feng, Haipeng, et al.
Publicado: (2020)

Benzyl-isothiocyanate Induces Apoptosis and Inhibits Migration and Invasion of Hepatocellular Carcinoma Cells in vitro
por: Zhu, Mingyue, et al.
Publicado: (2017)

Alpha fetoprotein antagonises benzyl isothiocyanate inhibition of the malignant behaviors of hepatocellular carcinoma cells
por: Zhu, Mingyue, et al.
Publicado: (2016)

Downregulation of MARC2 Promotes Immune Escape and Is Associated With Immunosuppression of Hepatocellular Carcinoma
por: Wu, Dehai, et al.
Publicado: (2022)

MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming
por: Zhang, Ze, et al.
Publicado: (2019)

Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
por: Nakagawa, Hayato, et al.
Publicado: (2018)

Glutamine metabolic reprogramming in hepatocellular carcinoma
por: Ye, Yanyan, et al.
Publicado: (2023)

Shuyu pills inhibit immune escape and enhance chemosensitization in hepatocellular carcinoma
por: Deng, Zhe, et al.
Publicado: (2021)

Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma
por: Xia, Yujia, et al.
Publicado: (2021)

METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression
por: Xia, Peng, et al.
Publicado: (2023)

Ezrin promotes hepatocellular carcinoma progression by modulating glycolytic reprogramming
por: Wang, Xinyue, et al.
Publicado: (2020)

Paraspeckle Promotes Hepatocellular Carcinoma Immune Escape by Sequestering IFNGR1 mRNA
por: Zan, Jie, et al.
Publicado: (2021)

Deoxyribonuclease 1-like 3 Inhibits Hepatocellular Carcinoma Progression by Inducing Apoptosis and Reprogramming Glucose Metabolism
por: Xiao, Yusha, et al.
Publicado: (2022)

Metabolic Reprogramming and Its Relationship to Survival in Hepatocellular Carcinoma
por: Wang, Qingqing, et al.
Publicado: (2022)

Na, K-ATPase α1 cooperates with its endogenous ligand to reprogram immune microenvironment of lung carcinoma and promotes immune escape
por: Yang, Kaiyong, et al.
Publicado: (2023)

Metabolic Reprogramming and Immune Evasion in Nasopharyngeal Carcinoma
por: Huang, Huimei, et al.
Publicado: (2021)

Norcholic Acid Promotes Tumor Progression and Immune Escape by Regulating Farnesoid X Receptor in Hepatocellular Carcinoma
por: Gong, Yihang, et al.
Publicado: (2021)

Molecular Analysis of AFP and HSA Interactions with PTEN Protein
por: Zhu, Mingyue, et al.
Publicado: (2015)

SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis
por: Xu, Kangdi, et al.
Publicado: (2022)

Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells
por: Huang, Mingyao, et al.
Publicado: (2022)

Multi-omics Analysis of Microenvironment Characteristics and Immune Escape Mechanisms of Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2019)

Deficiency of the X-inactivation escaping gene KDM5C in clear cell renal cell carcinoma promotes tumorigenicity by reprogramming glycogen metabolism and inhibiting ferroptosis
por: Zheng, Qian, et al.
Publicado: (2021)

Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling
por: Wang, Shanshan, et al.
Publicado: (2018)

BNIP3L-Dependent Mitophagy Promotes HBx-Induced Cancer Stemness of Hepatocellular Carcinoma Cells via Glycolysis Metabolism Reprogramming
por: Chen, Yuan-Yuan, et al.
Publicado: (2020)

Prognostic roles of metabolic reprogramming-associated genes in patients with hepatocellular carcinoma
por: Cui, Lijuan, et al.
Publicado: (2020)

The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma
por: Liao, Wenwei, et al.
Publicado: (2022)

GPR81-mediated reprogramming of glucose metabolism contributes to the immune landscape in breast cancer
por: li, Xiaofeng, et al.
Publicado: (2023)

Author Correction: Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling
por: Wang, Shanshan, et al.
Publicado: (2019)

Publisher Correction: Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling
por: Wang, Shanshan, et al.
Publicado: (2019)

LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma
por: Tao, Mingyue, et al.
Publicado: (2021)

MiR-103a promotes tumour growth and influences glucose metabolism in hepatocellular carcinoma
por: Liu, Yuling, et al.
Publicado: (2021)

Alpha-Fetoprotein Binding Mucin and Scavenger Receptors: An Available Bio-Target for Treating Cancer
por: Lin, Bo, et al.
Publicado: (2021)

Glucose Metabolic Reprogramming and Cell Proliferation Arrest in Colorectal Micropapillary Carcinoma
por: Vyas, Monika, et al.
Publicado: (2019)

The Role of Reprogrammed Glucose Metabolism in Cancer
por: Ediriweera, Meran Keshawa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9js6pbj8cdvks10893nv6ki0m5